The pharmacy quality assurance commission hereby designates, the following Schedule II controlled substances as nonnarcotic stimulants for purposes of RCW
69.50.402 (1)(c):
(1) Amphetamine sulfate in any of its generic forms.
(2) Dextroamphetamine sulfate in any of its generic forms and under the following brand names:
(a) Dexedrine (SKF);
(b) Dexedrine spansules (SKF).
(3) Dextroamphetamine HCL in any of its generic forms.
(4) Dextroamphetamine tannate in any of its generic forms.
(5) Methamphetamine HCL (Desoxyephedrine HCL) in any of its generic forms and under the following brand name:
Desoxyn (Abbott).
(6) Amphetamine complex in any of its generic forms and under the following brand names:
(a) Biphetamine 12 1/2 (Pennwalt);
(b) Biphetamine 20 (Pennwalt).
(7) Combined amphetamines sold under the following brand names:
Obetrol-10 and 20 (Obetrol).
(8) Phenmetrazine HCL in any of its generic forms and under the following brand name:
Preludin (Boehringer-Ingelheim).
(9) Methylphenidate HCL in any of its generic forms and under the following brand name:
Ritalin (Ciba).
(10) Lisdexamfetamine in any of its generic forms and under the following brand name:
Vyvanse.
[Statutory Authority: RCW
18.64.005 and
69.50.402. WSR 16-11-059, § 246-887-040, filed 5/13/16, effective 6/13/16. Statutory Authority: RCW
18.64.005. WSR 92-04-029 (Order 239B), § 246-887-040, filed 1/28/92, effective 2/29/92. Statutory Authority: RCW
18.64.005 and chapter
18.64A RCW. WSR 91-18-057 (Order 191B), recodified as § 246-887-040, filed 8/30/91, effective 9/30/91. Statutory Authority: RCW
69.50.201. WSR 79-08-069 (Order 148, Resolution No. 7-79), § 360-36-115, filed 7/24/79.]